Where to for precision treatment of HNF1A-MODY?

Diabetologia. 2022 Nov;65(11):1825-1829. doi: 10.1007/s00125-022-05696-4. Epub 2022 Apr 12.

Authors

Caroline Bonner¹, Chiara Saponaro²

Affiliations

¹ Inserm, CHU Lille, Institut Pasteur de Lille, University of Lille, Lille, France. caroline.bonner@univ-lille.fr.
² Inserm, CHU Lille, Institut Pasteur de Lille, University of Lille, Lille, France.

PMID: 35412067
DOI: 10.1007/s00125-022-05696-4

No abstract available

Keywords: HNF1A-MODY; Personalised medicine; Precision medicine.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Diabetes Mellitus, Type 2*
Hepatocyte Nuclear Factor 1-alpha* / genetics
Humans

Substances

HNF1A protein, human
Hepatocyte Nuclear Factor 1-alpha

Supplementary concepts

Mason-Type Diabetes